Yes. Week 28 scores are the primary endpoint which should be announced any day now. Week 42 scores are a secondary endpoint which should be announced next year.
Patients only receive doses in the first part of the trial, while the second part is more about seeing how long the effects last after dosing has stopped.
Market Data 
Markets 
AI
